Concepedia
Statistics
Publications
89
Citations
5.1K
H-Index
39
Active since
1984
Affiliations
National Cancer Institute(Current)
Frederick National Laboratory for Cancer Research
Center for Cancer Research
Leidos (United States)
Science Applications International Corporation (United States)
Ralph E. Parchment is an author at National Cancer Institute specializing in medicine, pharmacology, and oncology.
Publications per year
1984–2025
Phase 0 Clinical Trial of the Poly (ADP-Ribose) Polymerase Inhibitor ABT-888 in Patients With Advanced Malignancies
Shivaani Kummar, Robert J. Kinders, Martin Gutierrez et al. · Journal of Clinical Oncology · 2009 · 329 citations · Full text
Medicine, Oncology, Pharmacology +16
Guidelines for the Development and Incorporation of Biomarker Studies in Early Clinical Trials of Novel Agents
Janet Dancey, Kevin K. Dobbin, Susan Groshen et al. · Clinical Cancer Research · 2010 · 257 citations · Full text
Pharmacy, Pharmacology, Clinical Pharmacology +16
Phase I Study of PARP Inhibitor ABT-888 in Combination with Topotecan in Adults with Refractory Solid Tumors and Lymphomas
Shivaani Kummar, Alice P. Chen, Jiuping Ji et al. · Cancer Research · 2011 · 255 citations
Medicine, Oncology, Pharmacology +17
Hydrogen peroxide as a mediator of programmed cell death in the blastocyst
G. Barry Pierce, Ralph E. Parchment, Andrea L. Lewellyn · Differentiation · 1991 · 206 citations
Life Sciences, Biology, Cell Biology +14
A Phase I Study of Veliparib in Combination with Metronomic Cyclophosphamide in Adults with Refractory Solid Tumors and Lymphomas
Shivaani Kummar, Jiuping Ji, Robert J. Morgan et al. · Clinical Cancer Research · 2012 · 201 citations · Full text
1–5 of 89